Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,536.1
20.4 (0.81%)

 

  • STI Straits Times Index
    2,536.1
    20.4 (0.81%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,573.9
    -2.0 (-0.13%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,102.5
    155.9 (0.62%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,377.6
    5.9 (0.17%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,514.8
    -58.8 (-0.26%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,127.1
    52.0 (1.03%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,259.1M
  • Value: 1,115.6M
  • Rise: 214
  • Fall: 115
  • Unch: 479

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Leader Env0.066+0.010
Rex Intl0.186+0.003
AnAn Intl0.043+0.008
Synagie0.196+0.007
LionGold0.002-
Genting Sing0.705-0.025
Medtecs Intl1.030+0.045
CNMC Goldmine0.355+0.045
Anchor Resources0.009+0.002
ComfortDelGro1.390+0.040

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

INOVIO PHARMACEUTICALS INC INOVIO PHARMACEUTICALS
Updated on 04 Aug 2020 (End of trading day)
Last (USD): 20.315 Change: -0.375 High: 21.060 Remarks: -
Change (%): -1.81 Low: 19.820
Open 20.380 Yesterday's Close 20.69
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 10,468,160 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.75498 Trailing EPS (USD) e -0.77599 NAV (USD) b 1.1659
PE a - Trailing PE f - Price / NAV b 17.4243
Dividend (USD) d - Cash In Hand (USD) g 1.0022 Issued & Paid-up Shares c 158,096,000
Dividend Yield (%) d - Price / Cash In Hand g 20.270 Treasury Shares h -
Market Cap (M) 3,211.720 Enterprise Value (M) 3,043.773
Piotroski F Score 1 Exchange Code INO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 191.63 Free Float (%) 97.6
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference INOVIO PHARMACEUTICALS INC NASDAQ 3,211.720 - - 17.4243 -
Industry Medical Specialties NASDAQ 2,641.736 530.972 151.963 8.7685 0.035
Local Peer INTUITIVE SURGICAL INC NASDAQ 79,987.271 57.991 70.411 9.1513 -
Local Peer DEXCOM INC NASDAQ 42,307.521 418.472 206.681 31.2486 -
Local Peer IDEXX LABORATORIES INC NASDAQ 33,192.597 77.604 72.039 - -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 23,060.815 71.020 65.783 10.8926 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 22,711.842 51.294 13.350 7.9830 -
Local Peer HOLOGIC INC NASDAQ 18,662.459 - 28.268 8.2756 -
Local Peer ABIOMED INC NASDAQ 13,754.216 67.752 67.752 12.9091 -
Local Peer INSULET CORPORATION NASDAQ 13,507.845 1,164.485 2,620.847 228.9439 -
Local Peer QUIDEL CORP NASDAQ 12,524.622 171.756 81.057 - -
Local Peer MASIMO CORPORATION NASDAQ 11,934.178 60.822 53.701 8.8760 -
Local Peer DENTSPLY SIRONA INC NASDAQ 10,228.845 38.908 122.063 2.1822 0.811
Local Peer NOVOCURE LTD NASDAQ 7,901.273 - 669.770 29.5021 -
Other Local Peers BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), INARI MEDICAL INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), ATRICURE INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), MESA LABORATORIES INC (NASDAQ), CERUS CORP (NASDAQ), INMODE LTD (NASDAQ), ATRION CORP (NASDAQ), HESKA CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), VERICEL CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), INOGEN INC (NASDAQ), ZYNEX INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), QUOTIENT LTD (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), SI BONE INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), AXOGEN INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), VIEWRAY INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), PROFOUND MED CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), IRADIMED CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), MISONIX INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), FONAR CORP (NASDAQ), DERMTECH INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLITON INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), ELECTROCORE INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), CONFORMIS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), TITAN MEDICAL INC (NASDAQ), NEURONETICS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), IMMUCELL CORP (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), CELSION CORPORATION (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), AVINGER INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), CYANOTECH CORP (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), DIGIRAD CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DYNATRONICS CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NEUROMETRIX INC (NASDAQ), CANCER GENETICS INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 176,929.063 48.262 57.575 5.7862 1.315
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 164,454.259 44.495 44.304 5.4959 0.185
Global Peer DANAHER CORP NYSE 146,187.913 58.738 50.046 4.4307 0.324
Global Peer MEDTRONIC PLC NYSE 129,153.777 26.969 26.969 2.5456 2.243
Global Peer BECTON DICKINSON & CO NYSE 80,184.870 74.108 88.115 3.8276 1.045
Global Peer STRYKER CORP NYSE 71,102.216 34.135 44.319 - 1.127
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,077.319 11.293 13.336 - -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,625.361 45.492 64.047 12.4053 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 48,130.930 36.849 43.198 3.9128 1.697
Global Peer BAXTER INTERNATIONAL INC NYSE 41,045.291 41.004 44.421 5.0499 1.048
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), Top Glove (SGX), TOPGLOV (Bursa), VARIAN MEDICAL SYSTEMS INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), HARTA (Bursa), STERIS PLC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), PERKINELMER INC (NYSE), WATERS CORP (NYSE), WEIGAO GROUP (HKEx), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), SUPERMX (Bursa), KANGJI MEDICAL (HKEx), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), AK MEDICAL (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), PEIJIA-B (HKEx), CONMED CORP (NYSE), EBOS GROUP (ASX), GLAUKOS CORPORATION (NYSE), CANTEL MEDICAL CORP (NYSE), AVANOS MEDICAL INC (NYSE), VAPOTHERM INC (NYSE), NANOSONICS LIMITED (ASX), KDL MEDICAL (HKEx), LIFETECH SCI (HKEx), CIRC (HKEx), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), UG Healthcare (SGX), Medtecs Intl (SGX), YESTAR HEALTH (HKEx), RETRACTABLE TECHNOLOGIES INC (NYSE American), ALPHA PRO TECH (NYSE American), MCP INCOME OPPORTUNITIES TRUST (ASX), PW MEDTECH (HKEx), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), AROA BIOSURGERY LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), CORMEDIX INC (NYSE American), INVACARE CORP (NYSE), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), VINCENT MED (HKEx), MODERN DENTAL (HKEx), ELECTROMED INC (NYSE American), ATOMO DIAGNOSTICS LIMITED (ASX), LKL (Bursa), VOLITIONRX LIMITED (NYSE American), EMVISION MEDICAL DEVICES LTD (ASX), CYCLOPHARM LIMITED (ASX), Biolidics (SGX), SOMNOMED LIMITED (ASX), DAXOR CORP (NYSE American), RESAPP HEALTH LIMITED (ASX), YUNNAN ENERGY (HKEx), DIMERIX LTD (ASX), MILESTONE SCIENTIFIC INC (NYSE American), RESPIRI LTD (ASX), SDI LTD (ASX), COMPUMEDICS (ASX), KELFRED (HKEx), IMPEDIMED LIMITED (ASX), ONCOCYTE CORP (NYSE American), RESONANCE HEALTH LTD (ASX), MICRO-X LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), NOVA EYE MEDICAL LIMITED (ASX), Yunnan Energy (SGX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), OVENTUS MEDICAL LTD (ASX), LBT INNOVATIONS LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), LIFE HEALTHCARE (HKEx), USCOM LTD (ASX), METALICITY LIMITED (ASX), XTANT MEDICAL HLDGS INC (NYSE American), CARDIEX LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OPTISCAN IMAGING (ASX), ADHERIUM LIMITED (ASX), Annica (SGX), RA MEDICAL SYSTEMS INC (NYSE), STHAI (SET), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.835
+4.29 %
10 Days --5.875
-22.43 %
20 Days --3.145
-13.41 %
Medium Term Return 3 Months -+9.845
+94.03 %
6 Months -+16.755
+470.65 %
1 Year -+17.785
+702.96 %
Long Term Return 2 Years -+15.835
+353.46 %
3 Years -+14.685
+260.83 %
5 Years -+12.495
+159.78 %
Annualised Return Annualised --
+21.04 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.915 - 33.790 Change From 1 Year Low +18.400 % Change From 1 Year Low (%) +960.84
Change From 1 Year High -13.475 % Change From 1 Year High (%) -39.88
2 Years Range 1.915 - 33.790 Change From 2 Years Low +18.400 % Change From 2 Years Low (%) +960.84
Change From 2 Years High -13.475 % Change From 2 Years High (%) -39.88
5 Years Range 1.915 - 33.790 Change From 5 Years Low +18.400 % Change From 5 Years Low (%) +960.84
Change From 5 Years High -13.475 % Change From 5 Years High (%) -39.88
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system’s tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Historical Price Data

Date Open High Low Close Volume VWAP
04 Aug 2020 20.380 21.060 19.820 20.315 10,468,160 -
03 Aug 2020 19.570 20.700 18.720 20.690 17,507,160 -
31 Jul 2020 20.680 21.024 19.290 19.440 18,307,830 -
30 Jul 2020 21.210 22.930 20.134 20.730 44,011,480 -
29 Jul 2020 21.130 21.410 19.070 19.480 21,246,840 -
28 Jul 2020 20.460 22.780 20.350 20.790 20,442,270 -
27 Jul 2020 23.020 23.050 20.070 21.080 19,515,220 -
24 Jul 2020 23.050 23.050 21.520 21.910 16,806,640 -
23 Jul 2020 25.650 26.230 24.150 24.580 15,119,710 -
22 Jul 2020 25.930 26.730 25.110 26.190 18,158,970 -
21 Jul 2020 25.560 27.950 24.660 27.050 22,204,830 -
20 Jul 2020 26.970 27.500 24.100 25.370 21,258,850 -
17 Jul 2020 25.300 27.790 25.230 26.970 38,040,560 -
16 Jul 2020 23.650 24.650 23.160 24.570 11,949,720 -
15 Jul 2020 25.400 25.480 23.470 24.510 21,947,600 -
14 Jul 2020 27.010 28.140 24.639 26.210 31,238,430 -
13 Jul 2020 23.470 28.541 23.430 25.620 57,004,620 -
10 Jul 2020 23.130 23.650 22.650 23.380 16,811,600 -
09 Jul 2020 23.000 24.523 22.910 23.270 23,857,250 -
08 Jul 2020 22.800 24.390 22.530 23.460 28,355,510 -
07 Jul 2020 21.000 24.990 20.750 24.090 62,207,120 -
06 Jul 2020 21.620 21.870 19.530 20.930 39,617,110 -
Summary
Current 2 Weeks
(22 Jul 2020 to 04 Aug 2020)
25.930 26.730 18.720 20.315 201,584,280 -
Previous 2 Weeks
(08 Jul 2020 to 21 Jul 2020)
22.800 26.730 18.720 27.050 272,668,970 -
4 Weeks from
(09 Jun 2020 to 07 Jul 2020)
12.000 26.730 11.900 24.090 1,148,451,480 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.